|
Volumn 485, Issue 1, 2009, Pages 49-55
|
Equine cytochrome P450 2C92: cDNA cloning, expression and initial characterization
|
Author keywords
CYP2C; CYP450; Diclofenac; Horse; Mephenytoin; Phase I metabolism; Tolbutamide; Warfarin
|
Indexed keywords
COMPLEMENTARY DNA;
CYTOCHROME P450 2C;
CYTOCHROME P450 2C92;
DICLOFENAC;
OXIDOREDUCTASE;
OXYGENASE;
RECOMBINANT PROTEIN;
REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE;
TOLBUTAMIDE;
UNCLASSIFIED DRUG;
WARFARIN;
ANIMAL EXPERIMENT;
ANIMAL TISSUE;
ARTICLE;
BACULOVIRUS EXPRESSION SYSTEM;
ENZYME ACTIVITY;
ENZYME METABOLISM;
FEMALE;
GENE EXPRESSION;
GENE SEQUENCE;
HORSE;
LIVER;
MOLECULAR CLONING;
NONHUMAN;
PRIORITY JOURNAL;
PROTEIN DEGRADATION;
PROTEIN PURIFICATION;
ANIMALS;
BIOCATALYSIS;
CLONING, MOLECULAR;
CYTOCHROME P-450 ENZYME SYSTEM;
DICLOFENAC;
DNA, COMPLEMENTARY;
GENE EXPRESSION;
HORSES;
HUMANS;
KINETICS;
LIVER;
MOLECULAR SEQUENCE DATA;
SPECIES SPECIFICITY;
SPODOPTERA;
SUBSTRATE SPECIFICITY;
EQUIDAE;
|
EID: 64549119690
PISSN: 00039861
EISSN: 10960384
Source Type: Journal
DOI: 10.1016/j.abb.2009.02.009 Document Type: Article |
Times cited : (19)
|
References (17)
|